SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome

OBJECTIVES: To evaluate the interferon (IFN) biomarkers sialic acid binding Ig like lectin 1 (SIGLEC1, CD169) and IFN-γ-inducible protein-10 (IP-10) in patients with primary Sjögren's syndrome (pSS). METHODS: 31 patients fulfilling the American-European criteria for pSS were included. Disease a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Thomas, Szelinski, Franziska, Lisney, Anna, Reiter, Karin, Fleischer, Sarah J, Burmester, Gerd R, Radbruch, Andreas, Hiepe, Falk, Grützkau, Andreas, Biesen, Robert, Dörner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Sjögren Syndrome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237743/
https://www.ncbi.nlm.nih.gov/pubmed/28123773
http://dx.doi.org/10.1136/rmdopen-2016-000292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237743/
https://www.ncbi.nlm.nih.gov/pubmed/28123773
http://dx.doi.org/10.1136/rmdopen-2016-000292

Ejemplares similares